Corel Medical Series: Cancer/Corel Medical Series: Cancer.iso/pc/program/indexdat/indexa.h

Text File | 1997-01-27 | 3.5 KB | 2 lines

Hair loss,2,Hairy cell leukemia,c18.27,Haldol,chr.p17.14,Hallucinogens and sexuality,p23.8,Haloperidol,chr.p17.14,Haloteshn,c06.26;c06.48,Halsted radical mastectomy,c06.20,Hashimoto's thyroidids,c42.5,Head diagram,c14a.2,Head and neck cancer,12,Headache,p20.5,Health Care Financing Administration,p32a.3,Health care team,p03.1,Health Maintenance Organization (HMO),p32a.5,Healthy People 2000 Objectives,p34.4;p34.14,Heartburn,p06.18,Heel and elbow protectors,p26.5,Hemangioendothelioma,c19.1;c19.17,Hematogenous spread,p01.10,Hematologist,p03.4;p07.9,Hematoporphyrin,p09.4;p09.10;c04.18;c37.19,Hemodilution,p14.10,Hemorrhoids,c02.3,Heparin,p07.10,Hepatitis,2,Hepatoblastoma,c10a.2,Heredity,6,Herpes simplex,c09.5,Herpes zoster,p20.3,Hexalen,chr.p17.13,Hexamethylene bisacetamide,c18.14,Hexamethylmelamine,c29.19;c29.24,High Linear Energy Transfer (LET) radiation,p06.14,Histamine receptor blockers,c15.11,Histiocytosis X,c10a.2,HLA typing,p12.5;p12.25;p14.5,Hodgkin's disease,19,Home care,9,Home care nurse,p15.10,Homeopathy,p13.4,Hope,p29.7;p30.8;p32.8,Hormonal therapy,5,Hormones,3,Hospice nurse,p15.10,Hospital attendant,p15.8,Hospital staff nurse,p15.8,Hoxsey Treatment,p13.5,HTLV I,p14.3,Human immunodeficiency virus (HIV),6,Human papilloma virus (HPV),5,Humoral immunity,p20.2,Hurricane,p17.18,Hybridoma,p08.14,Hydatidiform mole,c43.2,Hydrea,chr.p17.13;c18.13;c18.24,Hydrocodone,p19.8,Hydromorphone,p19.13,Hydroxyurea,chr.p17.13;p35.19;c18.13,Hyperalimentation,p18.13,Hypercalcemia,c28.16;c32.9,Hyperfractionation,p06.14,Hypertension,c45.4,Hyperthermia,4,Hyperthermic perfusion therapy,6,Hyperthyroidism,c41.2,Hyperviscosity,c28.18,Hypopharynx tumor,c14a.2;c14a.7;c14b.29,Hypophysectomy,c05.19;c06.48;c34.5,Hypopituitarism,c41.2,Hysterectomy,5,
causes,p06.18;p07.26;p17.38,reducing,p17.39,child,c10a.7,diagnosis,c14a.8,investigational drugs,p35.12,questions to ask,c14b.43,recurrence,c14b.7;c14b.13;c14b.19;c14b.23;c14b.28;c14b.32;c14b.39;c14b.42,risk factors,c14a.5,screening,c14a.6,staging,c14a.9,symptoms,c14a.7,treatment,c14b.2,types,c14a.1,unknown primary site,c07.1;c07.11;c14b.40,and blood transfusion,p14.3,risk factor,c19.2,breast cancer,c06.4,childhood cancers,c10c.1,colorectal cancer,c11a.4,ovarian cancer,c29.3,risk factor,p01.8;p34.5,thyroid cancer,c42.3,causes,c23.5,child,c10a.2;c10a.7,diagnosis,c23.9,follow-up,c23.20,investigational drugs,p35.12,Iymphocyte depletion,c23.4,Iymphocyte predominant,c23.3,mixed cellularity,c23.3,questions to ask,c23.23,recurrence,c23.22,risk factors,c23.6,screening,c23.7,and sexuality,p23.7,spread,c23.4,staging,c23.11,symptoms,c23.8,treatment,p12.20;c23.13,types,p01.13;c23.2,unknown primary site,c07.1,body care,p26.8,choosing,p26.2,costs,p26.7,emergencies,p26.17,equipment,p26.4,pain control,p26.12,planning,p26.3,support services,p26.15,treatment services,p26.2,for breast cancer,c06.6;c06.25;c06.41;c06.45,for gynecological tumor,p23.6,for prostate cancer,c35.16,for uterine cancer,c44.12,risk factor,c19.3;c44.3,in chemotherapy,p07.6,promote cancer,p01.7,risk factor,c35.3,anal cancer,c02.3,Kaposi's sarcoma,c16.1,Iymphoma,c24.4;c22.1,risk factor,c24.5;c37.5;c40.4,skin cancer,c37.5,testis cancer,c40.4,anal cancer,c02.3,cervical cancer,c09.2,penile cancer,c33.2,vaginal cancer,c46.2,vulvar cancer,c47.2,choosing,p10.6,how it works,p10.3,in combination therapy,p06.13;p10.3,side effects,p10.5,choosing,p11.3,defined,p11.1,drugs used,p11.5,how it works,p11.6,illustration,p11.6,side effects,p11.8,cervix cancer,c09.15,endometrial carcinoma,c44.9,ovarian cancer,c29.16;c30.12,and sexuality,p23.6,uterine sarcoma,c45.10,